[ANR] YoY Quarter Result on 31-Dec-2017 [#Q2]

Stock
[ANR] Anatara Lifesciences Ltd
Announcement Date
30-Dec-2017
Financial Year
2018
Quarter
31-Dec-2017 [#Q2]
Profit Trend
QoQ- -31.24%
YoY- -325.37%
Quarter Report
ANR's Result
ANR's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 686 417 487 853 1,936 165 0 -
PBT -1,625 -2,221 -2,021 -1,710 -402 -1,179 -776 13.09%
Tax -596 -417 0 0 0 106 48 -
NP -1,029 -1,803 -2,021 -1,710 -402 -1,179 -776 4.81%
Tax Rate - - - - - - - -
Total Cost 1,715 2,221 2,508 2,563 2,338 1,344 776 14.11%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -150.15 -432.09 -415.32 -200.56 -20.78 -713.59 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.01 -0.03 -0.04 -0.03 -0.01 -0.03 -0.03 -16.71%
EPS Diluted -0.01 -0.03 -0.04 -0.03 -0.01 -0.03 -0.03 -16.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.